Metrion
Metrion is a specialist preclinical CRO and recognised leader in ion channel electrophysiology and cardiac safety screening, with deep expertise in pain drug discovery. Our scientific leadership team brings over 125 years of combined drug discovery experience, including pioneering research into NaV1.7, NaV1.8 and NaV1.9. We provide high-quality AI-ready data, insightful interpretation, and collaborative scientific support to help pharmaceutical and biotechnology companies advance novel pain therapeutics from target validation through to lead optimisation.
